Advertisement

Topics

Alexion, Moderna end partnership

08:57 EDT 1 Aug 2017 | CentreWatch

Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, provided an update on its rare disease Research & Development (R&D) strategy, issuing the following statement related to Alexion Pharmaceuticals R&D realignment announcement. Alexion announced that it plans to […]

The post Alexion, Moderna end partnership appeared first on CenterWatch News Online.

Original Article: Alexion, Moderna end partnership

NEXT ARTICLE

More From BioPortfolio on "Alexion, Moderna end partnership"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...